References
- WHO. Global strategy for infant and young child feeding. Geneva: WHO; 2003.
- Nguyen B, Jin K, Ding D. Breastfeeding and maternal cardiovascular risk factors and outcomes: a systematic review. PLoS One. 2017;12(11):e0187923.
- McClure CK, Catov JM, Ness RB, et al. Lactation and maternal subclinical cardiovascular disease among premenopausal women. Am J Obstet Gynecol. 2012;207(1):2. [Research Support, N I H, Extramural].
- Ram KT, Bobby P, Hailpern SM, et al. Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife – SWAN, the Study of Women’s Health Across the Nation. Am J Obstet Gynecol. 2008;198(3):268.e1-268–e6.
- Gunderson EP, Quesenberry CP, Ning X, et al. Lactation duration and midlife atherosclerosis. Obstet Gynecol. 2015;126(2):381–390.
- Lambrinoudaki I, Kazani A, Armeni E, et al. The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women. Gynecol Endocrinol. 2018;34(1):78–82.
- Lambrinoudaki I, Kazani MV, Armeni E, et al. The TyG Index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women. Heart Lung Circ. 2018;27(6):716–724.
- Lambrinoudaki I, Stergiotis S, Chatzivasileiou P, et al. Anti-Mullerian hormone concentrations are inversely associated with subclinical atherosclerosis in premenopausal women. Angiology. 2020;71(6):552–558.
- Stein JH, Korcarz CE, Post WS. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: summary and discussion of the American Society of Echocardiography Consensus Statement. Prev Cardiol. 2009;12(1):34–38.
- Schwarz EB, Ray RM, Stuebe AM, et al. Duration of lactation and risk factors for maternal cardiovascular disease [Research Support, N I H, Extramural]. Obstet Gynecol. 2009;113(5):974–982.
- Zachou G, Armeni E, Lambrinoudaki I. Lactation and maternal cardiovascular disease risk in later life. Maturitas. 2019;122:73–79.
- Peters SA, van der Schouw YT, Wood AM, et al. Parity, breastfeeding and risk of coronary heart disease: a pan-European case-cohort study [Multicenter Study Research Support, Non-U S Gov’t]. Eur J Prev Cardiolog. 2016;23(16):1755–1765.
- Peters S. Breastfeeding and the risk of maternal cardiovascular disease: a prospective study of 300 000 Chinese women. J Am Heart Assoc. 2017;6(6):006081.
- Natland Fagerhaug T, Forsmo S, Jacobsen GW, et al. A prospective population-based cohort study of lactation and cardiovascular disease mortality: the HUNT study [Research Support, Non-U S Gov’t]. BMC Public Health. 2013;13(1070):1070–2458.
- Karnik SK, Chen H, McLean GW, et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science (New York, NY). 2007;318(5851):806–809.
- Li J, Rice MS, Huang T, et al. Circulating prolactin concentrations and risk of type 2 diabetes in US women. Diabetologia. 2018;61(12):2549–2560.
- Poykko SM, Kellokoski E, Horkko S, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes. 2003;52(10):2546–2553.
- Jameson H, Bateman R, Byrne P, et al. Oxytocin neuron activation prevents hypertension that occurs with chronic intermittent hypoxia/hypercapnia in rats. Am J Physiol Heart Circ Physiol. 2016;310(11):H1549–57. 1
- Ding C, Leow MK, Magkos F. Oxytocin in metabolic homeostasis: implications for obesity and diabetes management [Review]. Obesity Rev. 2019;20(1):22–40.